Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to help answer the following research questions:
- whether the chemotherapy combination therapy Pemetrexed-Carboplatin or
Gemcitabine-Vinorelbine can help participants with advanced breast cancer to make the
tumor smaller or disappear and for how long
- to learn more about the side effects in each chemotherapy combination treatment arm
- to assess how participants with advanced breast cancer report health changes while
receiving any of the chemotherapy combination arm